Clinical Trial Update: Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Phase II clinical study to evaluate the efficacy and safety of AMP Peptide PL-5 in mild infections of diabetic foot ulcers; the trial is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• AMP Peptide PL-5 (PL-5 peptide)

Snippet

Sponsor: Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. | Conditions: Diabetic Foot Ulcers | Phase 2 | Status: ACTIVE_NOT_RECRUITING